FIELD: medicine.
SUBSTANCE: invention refers to ophthalmology and may be used for treating degenerative and dystrophic retinal diseases. That is ensured by subcutaneous introduction of the preparation Coenzyme compositum 0.5 ml within the mastoid process, the preparation Lymphomyosot - within the temporal fossa, as well as by parabulbar introduction of the preparation Placenta compositum. The course is 10 sessions every second day 1-2 days a year. The introductions are double-sided if the retina in both eyes is involved.
EFFECT: invention provides improving the peripheral circulation in the eyes, increasing visual acuity due to the integrated effect of the drugs administered.
2 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING RETINAL AND VITREOUS HEMORRHAGE | 2013 |
|
RU2513473C1 |
| METHOD OF TREATING RETICULAR PSEUDO-DRUSEN WITH MICRO-PULSE LASER ACTION | 2018 |
|
RU2696927C1 |
| METHOD OF TREATING EARLY MANIFESTATIONS OF AGE-RELATED MACULAR RETINAL DEGENERATION | 2014 |
|
RU2549673C1 |
| METHOD OF TREATING RETICULAR PSEUDO-DRUSEN | 2019 |
|
RU2727034C1 |
| METHOD OF TREATING AGE-RELATED MACULAR RETINAL DEGENERATION | 2009 |
|
RU2408335C1 |
| METHOD OF COMBINED LASER TREATMENT OF DRUSENOID SEPARATION OF RETINAL PIGMENT EPITHELIUM | 2019 |
|
RU2727035C1 |
| METHOD OF TREATMENT OF MYOPIC MACULOPATHY | 2023 |
|
RU2803580C1 |
| HOMEOPATHIC AGENT FOR TREATMENT OF RETINA DYSTROPHIC DISEASE | 2003 |
|
RU2240804C1 |
| METHOD OF TREATMENT OF MACULAR FOR AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2647142C1 |
| METHOD OF TREATING WET AGE-RELATED MACULAR DEGENERATION OF RETINA WITH USING CELL TRANSPLANTATION | 2011 |
|
RU2467727C2 |
